Altamira Therapeutics

Optimeos Life Sciences

This company develops nanoparticle drug delivery systems and long-acting injectables for pharmaceutical partners to enable targeted intracellular delivery of genetic medicines and proteins.

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Etherna

This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.

Breeze

This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.

Ariz Precision Medicine

The company develops targeted nanoparticle and siRNA therapies for cancer patients and pharmaceutical partners.

Orna Therapeutics

This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

NaDeNo

This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.